Myasthenia gravis in children: Analysis of 18 patients

Arquivos de Neuro-Psiquiatria

Volumn 59, Issue 3 B, 2001, Pages 681-685

  Da Penha A Morita, Maria ^a,c   Gabbai, Alberto A ^a   Oliveira, Acary S B ^a   Penn, Audrey S ^b,d  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b Och Spine at New York Presbyterian Hospitals   (United States)

^c FACULDADE DE MEDICINA DE SÃO JOSÉ DO RIO PRETO   (Brazil)

^d NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Child; Myasthenia gravis

Indexed keywords

AZATHIOPRINE; CHOLINERGIC RECEPTOR ANTIBODY; IMMUNOGLOBULIN; PREDNISONE; PYRIDOSTIGMINE;

ANTIBODY DETECTION; ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; DISEASE SEVERITY; ELECTROMYOGRAM; FEMALE; HUMAN; HUMAN TISSUE; LYMPHOID HYPERPLASIA; MALE; MYASTHENIA GRAVIS; NERVE STIMULATION; ONSET AGE; STEROID THERAPY; THYMECTOMY; TREATMENT FAILURE; TREATMENT OUTCOME;

EID: 0342419398     PISSN: 0004282X     EISSN: None     Source Type: Journal    
DOI: 10.1590/s0004-282x2001000500005     Document Type: Article

References (34)

1. Szorbor A, Máttyus A, Molnár J. Myasthenia gravis in childhood and adolescence: report on 209 patients and review of literature. Acta Paediatr Hung 1988-1989;29:299-312.
2. Snead OC, Benton JW, Dwyer D, et. al. Juvenile myasthenia gravis. Neurology 1980;30:732-739.
3. Andrew PI, Massey JM, Sanders DB. Acetylcholine receptor antibodies in juvenile myasthenia gravis. Neurology 1993;43:977-982.
4. Evoli A, Batocchi AP, Bartoccioni E, Lino MM, Minisci C, Tonali P. Juvenile myasthenia gravis with prepubertal onset. Neuromuscul Disord 1998;8:561-567.
5. Swaiman KF. Diseases of the neuromuscular junction. In Swaiman KF (ed.) Pediatric neurology. 2.Ed. Saint Louis: Mosby, 1994:1453-1476.
6. Evoli A, Batocchi AP, Tonali P, Marciano M. Risk of cancer in patients with myasthenia gravis. Ann N Y Acad Sci 1998;841:742-745.
7. Seybold ME. Thymectomy in childhood myasthenia gravis. Ann N Y Acad Sci 1998;841:731-741.
8. Rodriguez M, Gomez MR, Haward FM Jr, et al. Myasthenia gravis in children: long-term follow-up. Ann Neurol 1983;13: 504-510.
9. Lopes JR, Fontenele FA. Infantile myasthenia gravis: report of a case diagnosed clinically. Arq Neuropsiquiatr 1985;43:316-318.
10. Assis JL, Marchiori PE, Zambon AA, Scaff M. Juvenile myasthenia gravis and thymectomy: report of ten cases. Rev Hosp Clin Fac Med Sao Paulo 1992;47:234-236.
11. Cunha FM, Scola RH, Werneck LC. Myasthenia Gravis. Clinical evaluation of 153 patients. Arq Neuropsiquiatr 1999;57:457-464
12. Osserman KE, Genkins G. Studies in myasthenia gravis: a review of a twent-year experience in over 1200 patients. Mt Sinai J Med 1971;38:497-537.
13. AIDS to examination of peripheral nervous system. London: Ballière Tindall, 1986, 61 p.
14. Millichap JG, Dodge PR. Diagnosis and treatment of myasthenia gravis in infancy, childhood and adolescence: a study of 51 patients. Neurology 1960;10:1007-1014.
15. Batocchi AP, Evoli A, Palmisani MT, et al. Early-onset myasthenia gravis: clinical characteristics and response to therapy. Eur J Pediatr 1990;150:66-68.
16. Roach ES, Buono G, Mclean Jr W, Weaver Jr G. Early onset myasthenia gravis. J Pediatr 1986;108:193-197.
17. Seybold ME, Haward Jr FM, Duane DD, et al. Thymectomy in juvenile myasthenia gravis. Arch. Neurol 1971;25:385-392.
18. Horowitz SH, Genkins G, Kornfeld P, Paparestas AE. Eletrophysiologic diagnosis of myasthenia gravis and the regional curare test. Neurology 1976;26:410-417.
19. Oh SJ, Eslami N, Nishihira T, et. al. Electrophysiological and clinical correlation in myasthenia gravis. Ann Neurol 1982;12:348-354.
20. Sano M, Lambert EH, Mccormick DJ, Lennon VA. Muscle acetylcholine receptors complexed with autologous IgG reflect seropositivity but not necessarialy in vivo binding. Neurology 1992;42:218-222.
21. Newson-Davis J. Myasthenia gravis and myasthenic syndromes: autoimmune disease at the neuromuscular junction. Curr Opin Neurol Neurosurg 1991;4:683-688.
22. Yamamoto T, Vincent A, Ciulla TA, et al. Seronegative myasthenia gravis: a plasma factor inhibiting agonist-induced acetylcholine receptor function copurifies with IgM. Ann Neurol 1991;30:550-557.
23. Mishina M, Takai T, Imoto K, et. al. Molecular distinction between fetal and adult forms of muscle acetylcholine receptor. Nature 1986;321:406-411.
24. Komiya T, Sato T. Long-term follow-up study of relapse in symptoms and reelevation of acetylcholine receptor antibody titers in patients with myasthenia gravis. Ann NY Acad Sci 1988;540:605-607.
25. Limburg PC, The TH, Tappel EH, et al. Anti-acetylcholine receptor antibodies in myasthenia gravis: relation to clinical parameters in 250 patients, J Neurol Sci 1983;58:357-370.
26. Oosterhius HJGH, Limburg PC, Tappel EH, et al. Anti-acetylcholine receptor antibodies in myasthenia gravis: clinical and serological follow-up of individual patients. J Neurol Sci 1983;58:371-385.
27. Lettgen B. Influence of steroid medication on bone mineral density in children with nephrotic syndrome. Pediatr Nephrol 1994;8:667-670.
28. Gronseth GS, Barohn RJ. Practice parameter: Thymectomy for autoimmune myasthenia gravis (an evidence-based review). Neurology 2000;55:7-15.
29. Assis JL. Imunopatologia do timo. In Assis JL (ed.) Miastenia grave. São Paulo: Savier 1990:105-120.
30. Selcen D, Dabrowski ER, Michon AM, Nigro MA. High-dose intravenous immunoglobulin therapy in juvenile myasthenia gravis. Pediatr Neurol 2000;22:40-43.
31. Silman AJ, Petrie J, Hazleman B, Evans SJ. Lymphoproliferative cancer and other malignancy in patients with rheumatoid arthritis treated with azathioprine: a 20 year follow-up study. Ann Rheum Dis 1988;47:988-992.
32. Confavreux C, Saddier P, Grimaud J, Moreau T, Adeleine P, Aimard G. Risk of cancer from azathioprine therapy in multiple sclerosis: a case-control study. Neurology 1996;46:1607-1612.
33. Kerribijn KF, De Kroon JPM. Effect on height of corticosteroid therapy in asthmatic children. Arch Dis Child 1968;63:484-490.
34. Andrews PI. A treatment algorithm for autoimmune myasthenia gravis in children. Ann N Y Acad Sci 1998;841:789-802.